VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 627 filers reported holding VANECK VECTORS ETF TR in Q2 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,130,064 | -1.1% | 92,251 | -2.5% | 0.36% | +2.9% |
Q1 2024 | $3,163,512 | -1.7% | 94,603 | -8.8% | 0.34% | -11.1% |
Q4 2023 | $3,216,713 | -20.9% | 103,731 | -31.4% | 0.39% | -27.5% |
Q3 2023 | $4,068,940 | -8.6% | 151,206 | +2.2% | 0.54% | -5.3% |
Q2 2023 | $4,453,224 | -45.6% | 147,899 | -41.6% | 0.56% | -48.3% |
Q1 2023 | $8,186,632 | +34.5% | 253,064 | +19.2% | 1.09% | +19.5% |
Q4 2022 | $6,085,388 | +64.0% | 212,330 | +38.0% | 0.92% | +43.2% |
Q3 2022 | $3,710,000 | +825.2% | 153,817 | +1371.7% | 0.64% | +800.0% |
Q1 2022 | $401,000 | +36.4% | 10,452 | +13.7% | 0.07% | +34.0% |
Q4 2021 | $294,000 | +3.2% | 9,190 | -5.1% | 0.05% | -10.2% |
Q3 2021 | $285,000 | -22.1% | 9,688 | -10.0% | 0.06% | -27.2% |
Q2 2021 | $366,000 | +8.3% | 10,770 | +3.4% | 0.08% | -4.7% |
Q1 2021 | $338,000 | -27.2% | 10,412 | -19.2% | 0.08% | -88.2% |
Q4 2020 | $464,000 | -25.5% | 12,880 | -19.0% | 0.72% | +220.5% |
Q3 2020 | $623,000 | +26.1% | 15,905 | +18.0% | 0.22% | -77.5% |
Q2 2020 | $494,000 | +81.6% | 13,480 | +14.2% | 0.99% | +653.0% |
Q1 2020 | $272,000 | -2.2% | 11,804 | +21.7% | 0.13% | +20.0% |
Q4 2019 | $278,000 | +6.5% | 9,699 | +0.0% | 0.11% | +1.9% |
Q3 2019 | $261,000 | -2.2% | 9,696 | +2.1% | 0.11% | -6.9% |
Q2 2019 | $267,000 | +25.4% | 9,496 | 0.0% | 0.12% | +18.4% |
Q1 2019 | $213,000 | -3.6% | 9,496 | -9.5% | 0.10% | -10.9% |
Q4 2018 | $221,000 | +6.2% | 10,496 | +0.0% | 0.11% | +18.3% |
Q3 2018 | $208,000 | -14.8% | 10,494 | -4.1% | 0.09% | -13.9% |
Q2 2018 | $244,000 | +1.2% | 10,944 | 0.0% | 0.11% | +6.9% |
Q1 2018 | $241,000 | -5.1% | 10,944 | 0.0% | 0.10% | +20.2% |
Q4 2017 | $254,000 | +5.4% | 10,944 | +4.3% | 0.08% | +1.2% |
Q3 2017 | $241,000 | +3.9% | 10,490 | 0.0% | 0.08% | +1.2% |
Q2 2017 | $232,000 | -2.9% | 10,490 | 0.0% | 0.08% | -6.8% |
Q1 2017 | $239,000 | -80.9% | 10,490 | -82.5% | 0.09% | -75.4% |
Q4 2016 | $1,252,000 | – | 59,841 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |